HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

208.00p
   
  • Change Today:
      11.50p
  • 52 Week High: 352.00
  • 52 Week Low: 189.00
  • Currency: UK Pounds
  • Shares Issued: 871.60m
  • Volume: 304,296
  • Market Cap: £1,812.93m
  • RiskGrade: 226

Latest ShareCast News

Hutchmed renal cell carcinoma trial meets primary endpoint

By Josh White

Date: Wednesday 19 Mar 2025

(Sharecast News) - Hutchmed China, alongside Innovent Biologics, announced on Wednesday that the FRUSICA-2 phase two and three clinical trial evaluating the combination of fruquintinib and sintilimab as a second-line treatment for advanced renal cell carcinoma (RCC) in China had met its primary endpoint of progression-free survival.

HCM ShareCast News

Hutchmed announces progress, hits milestone with... 02-Jan-2025 ShareCast
Hutchmed to receive $10m milestone payment from ... 13-Dec-2024 ShareCast
Hutchmed lung cancer therapy gets breakthrough d... 12-Dec-2024 ShareCast
Hutchmed endometrial cancer treatment gets condi... 03-Dec-2024 ShareCast
Hutchmed partner launches Fruzaqla in Japan 22-Nov-2024 ShareCast

HCM Regulatory News

2024 Annual Report and Notice of AGM 07-Apr-2025 09:30 RNS
Extraordinary General Meeting – Poll Results 31-Mar-2025 10:30 RNS
Retirement of Independent Non-executive Directors 20-Mar-2025 09:30 RNS
2024 Final Results and Business Updates 19-Mar-2025 11:00 RNS
Adoption of the 2025 Long Term Incentive Plan 14-Mar-2025 09:30 RNS

HCM Newspaper Links

Chinese medicine firm employs Cambridge Universi... 23-Dec-2009 Guardian
Joint venture offers food for growth 09-Oct-2009 The Scotsman
Chi-Med unveils maiden profit 31-Jul-2009 The Scotsman
Chi-Med happy with drug tests 14-Jul-2009 The Scotsman
'Watershed' year depends on US drugs trial says ... 17-Mar-2009 The Scotsman

HCM Tips & Analysis

Questor: Hutchison China Meditech 03-Jul-2007 Telegraph
The Week Ahead: Wolseley investors seek calm ami... 19-Mar-2007 The Independent
The Investment Column: Hutchison China MediTech 21-Nov-2006 The Independent
Shares That Sound Good 02-Jun-2006 Motley Fool UK

HCM News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 208.00p
Change Today 11.50p
% Change 5.85 %
52 Week High 352.00
52 Week Low 189.00
Volume 304,296
Shares Issued 871.60m
Market Cap £1,812.93m
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.67% below the market average45.67% below the market average45.67% below the market average45.67% below the market average45.67% below the market average
31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average
Price Trend
50.53% below the market average50.53% below the market average50.53% below the market average50.53% below the market average50.53% below the market average
4.17% below the sector average4.17% below the sector average4.17% below the sector average4.17% below the sector average4.17% below the sector average
Income Not Available
Growth
45.48% below the market average45.48% below the market average45.48% below the market average45.48% below the market average45.48% below the market average
67.74% below the sector average67.74% below the sector average67.74% below the sector average67.74% below the sector average67.74% below the sector average

HCM Dividends

No dividends found

Trades for 11-Apr-2025

Time Volume / Share Price
16:35 958 @ 208.00p
16:35 49 @ 208.00p
16:35 353 @ 208.00p
16:35 194 @ 208.00p
16:35 45 @ 208.00p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page